We are live on ! Find out more
Brown Advisory

Brown Advisory Portfolio holdings

AUM $60.9B
1-Year Est. Return 15.24%
This Fund
S&P 500
This Quarter Est. Return
+9.66%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$39.4B
AUM Growth
+$3.78B
Cap. Flow
+$934M
Cap. Flow %
2.37%
Top 10 Hldgs %
22.56%
Holding
1,080
New
75
Increased
361
Reduced
442
Closed
44

Top Buys

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$242M
2
ILMN icon
Illumina
ILMN
+$98.3M
3
BIO icon
Bio-Rad Laboratories Class A
BIO
+$80.6M
4
AMZN icon
Amazon
AMZN
+$63.7M
5
FTV icon
Fortive
FTV
+$55.5M

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$61.6M
2
MTD icon
Mettler-Toledo International
MTD
+$54.4M
3
EW icon
Edwards Lifesciences
EW
+$47.2M
4
DHR icon
Danaher
DHR
+$46.2M
5
MSFT icon
Microsoft
MSFT
+$45.4M

Sector Composition

Rank Sector Weight
1 Technology 22.67%
2 Healthcare 17.29%
3 Financials 13.57%
4 Consumer Discretionary 12.51%
5 Industrials 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLDR
1001
DELISTED
Cloudera, Inc.
CLDR
$142K ﹤0.01%
12,182
AFMD
1002
DELISTED
Affimed
AFMD
$137K ﹤0.01%
5,000
CLPT icon
1003
ClearPoint Neuro
CLPT
$423M
$134K ﹤0.01%
28,000
NVAX icon
1004
Novavax
NVAX
$1.23B
$134K ﹤0.01%
33,800
-2,000
-6% -$8.67K
RGT
1005
Royce Global Value Trust
RGT
$95.8M
$127K ﹤0.01%
10,849
+1
+0% +$11
NG icon
1006
NovaGold Resources
NG
$2.6B
$125K ﹤0.01%
14,000
-5,132
-27% -$35.5K
BCDA icon
1007
BioCardia
BCDA
$12.7M
$122K ﹤0.01%
2,206
OCSL icon
1008
Oaktree Specialty Lending
OCSL
$1.03B
$109K ﹤0.01%
6,667
LTS
1009
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$104K ﹤0.01%
30,000
CFRX
1010
DELISTED
ContraFect Corporation
CFRX
$103K ﹤0.01%
208
LTHM
1011
DELISTED
Livent Corporation
LTHM
$94K ﹤0.01%
11,006
-1,944
-15% -$14.9K
ZIXI
1012
DELISTED
Zix Corporation
ZIXI
$93K ﹤0.01%
13,660
BBVA icon
1013
Banco Bilbao Vizcaya Argentaria
BBVA
$144B
$83K ﹤0.01%
14,800
-20,813
-58% -$111K
GOGO icon
1014
Gogo Inc
GOGO
$515M
$83K ﹤0.01%
+13,006
New +$75.7K
CTSO icon
1015
Cytosorbents Corp
CTSO
$22.6M
$70K ﹤0.01%
+18,200
New +$79.4K
EZPW icon
1016
Ezcorp Inc
EZPW
$1.82B
$70K ﹤0.01%
10,300
AR icon
1017
Antero Resources
AR
$10.9B
$69K ﹤0.01%
24,174
-17,614
-42% -$45K
NIO icon
1018
NIO
NIO
$11.3B
$68K ﹤0.01%
16,950
ADIL
1019
Adial Pharmaceuticals
ADIL
$6.08M
$63K ﹤0.01%
42
AEG icon
1020
Aegon
AEG
$13.5B
$62K ﹤0.01%
14,810
SAN icon
1021
Banco Santander
SAN
$194B
$62K ﹤0.01%
15,594
+3,203
+26% +$12.4K
NYMX
1022
DELISTED
Nymox Pharmaceutical Corp
NYMX
$59K ﹤0.01%
26,700
BMY.RT
1023
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$59K ﹤0.01%
+20,575
New +$53.5K
RRC icon
1024
Range Resources
RRC
$9.11B
$55K ﹤0.01%
11,346
-4,000
-26% -$16.1K
DNR
1025
DELISTED
Denbury Resources, Inc.
DNR
$51K ﹤0.01%
+36,490
New +$40.7K

Similar funds

Brown Advisory's Q4 2019 Portfolio in Review

As of Q4 2019, Brown Advisory held 1,080 positions worth $39.4B, up 11% from $35.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Brown Advisory's Q4 2019 filing shows 75 new, 361 increased, 442 reduced and 44 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 228,512 shares worth $84.6M. The largest sale was PayPal, an estimated $61.6M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Brown Advisory's largest Q4 2019 buy was Bio-Rad Laboratories Class A: 228,512 shares worth $84.6M.
  • Brown Advisory added most to L3Harris in Q4 2019, an estimated $242M increase.
  • Brown Advisory's biggest Q4 2019 reduction was PayPal, cutting an estimated $61.6M.
  • Brown Advisory fully exited Loral Space and Communications, Inc. in Q4 2019, selling an estimated $21.1M.
  • Brown Advisory's ten largest holdings make up 23% of its $39.4B portfolio in Q4 2019.
  • Brown Advisory opened 75 new positions and closed 44 in Q4 2019.
  • Brown Advisory's portfolio value rose 11% quarter-over-quarter to $39.4B.

Based on Brown Advisory's 13F filing for Q4 2019, filed 14 Feb 2020.